- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Noncontrast MR angiography creates equivalent image quality to contrast
Noncontrast MR angiography provides an alternative to the more common contrast-enhanced MRA administered with a gadubutrol-based agent, according to a report presented at the RSNA meeting Tuesday morning.
Noncontrast MR angiography provides an alternative to the more common contrast-enhanced MRA administered with a gadubutrol-based agent, according to a report presented at the RSNA meeting Tuesday morning.
Dr. Christopher Francois, an assistant professor of radiology at the University of Wisconsin, and colleagues imaged 12 healthy volunteers and 51 patients with a 3D phase-contrast sequence and a novel respiratory gated phase-contrast vastly undersampled isotropic projection reconstruction (PC VIPR) sequence.
The researchers also acquired contrast-enhanced MRA exams and 2D phase-contrast data for several of the patients.
Francois and colleagues evaluated the images based on quality and visibility of vessels. Two blinded radiologists compared vessel visibility acquired with CE-MRA and PC VIPR independently and in random order.
The blinded radiologists reported equivalent overall image quality for both protocols. Poor breath-holds compromised quality for some CE-MRA scans, while PC VIPR had reduced image quality in highly obese patients.
Because CE-MRA scans and PC VIPR showed equivalent overall image quality, Francois said PC VIPR is a good alternative to CE-MRA, especially for patients who are at risk for nephrogenic systemic fibrosis.
PC VIPR has become the standard protocol at the University of Wisconsin, he said.
Future analysis will investigate the correlation of transstenotic pressure gradients obtained noninvasively with PC VIPR and invasively under x-ray fluoroscopy, according to Francois.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
